Pharmacological activity of angiotensin-II modified by tyrosine sulfation.
スポンサーリンク
概要
- 論文の詳細を見る
An angiotensin-II analogue with a sulfated tyrosine residue was prepared by arylsulfotransferase treatment of synthetic human angjotensin-II. Its biological activities were studied in isolated smooth muscles, and its effect on blood pressure was determined. The sulfated angiotensin-II (All-S) was about 15-30 fold less potent than angjotensin-II (All) for ileum contraction and gallbladder contraction. The hypertensive potency of AII-S was about 30-fold less than that of All.
- 公益社団法人 日本薬理学会の論文
著者
-
MORIKAWA Tadanori
Fuji Chemical Industries, Ltd
-
KOBASHI Kyoichi
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
-
HAGIWARA Masaki
Fuji Chemical Industries, Ltd.
-
OHUCHI Eiko
Fuji Chemical Industries, Ltd.
-
HONGO Kazuya
Fuji Chemical Industries, Ltd.
-
OKI Miyuki
Fuji Chemical Industries, Ltd.
-
WADA Koichi
Fuji Chemical Industries, Ltd.
関連論文
- ENZYMATIC REDUCTION OF SENNIDIN AND SENNOSIDE IN PEPTOSTREPTOCOCCUS INTERMEDIUS
- INHIBITION OF CORNEAL ULCERATION BY TETRAPEPTIDYL HYDROXAMIC ACID
- Purification and Characterization of β-Glucosidase from Bacteroides JY-6,a Human Intestinal Bacterium
- The Role of Intestinal Bacteria in the Transformation of Sodium Picosulfate
- Pharmacological activity of angiotensin-II modified by tyrosine sulfation.
- Vasoactive intestinal polypeptide(VIP) stimulates fibrinolytic system in the rat.